Emergent BioSolutions Inc. (EBS) Investment Research Dashboard
About Emergent BioSolutions Inc. (EBS) stock analysis
Get live EBS stock price $7.33, comprehensive Emergent BioSolutions Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time EBS stock data and investment insights.
Loading chart data...
Emergent BioSolutions Inc. (EBS) Overview
Emergent BioSolutions Inc. (EBS) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, EBS trades at $7.33 with a market capitalization of 378.20M . Over the past 52 weeks, EBS has traded between $5.62 and $14.06 , with the current price positioned at approximately 20% of this range . The stock currently trades...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 378.20M
- Current price: $7.33
- 52-week range: $5.62 - $14.06
- P/E ratio: 7.33
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These threats encompass accidental, deliberate, and natu...
Company Information
- CEO
- Joseph C. Papa Jr.
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 900
Contact Information
- Address
- 400 Professional Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 7.3)
✓ Higher growth potential with elevated volatility (Beta: 2.34)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Emergent BioSolutions Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Emergent BioSolutions Inc.
- ⚠Investors should consider how Emergent BioSolutions Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
378.20M
P/E Ratio (TTM)
7.33
Beta
2.34
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare EBS with peer companies:
- Price
- $3.73+1.36% (1D)
- Market cap
- 467.99M
- Price
- $11.27+0.09% (1D)
- Market cap
- 1.52B
- Price
- $12.92-1.15% (1D)
- Market cap
- 1.09B
- Price
- $3.18+0.00% (1D)
- Market cap
- 661.15M
- Price
- $12.01+2.65% (1D)
- Market cap
- 1.05B
- Price
- $2.55+6.69% (1D)
- Market cap
- 328.12M
- Price
- $8.70-0.57% (1D)
- Market cap
- 455.47M
- Price
- $37.39+1.77% (1D)
- Market cap
- 691.79M
- Price
- $3.10-0.32% (1D)
- Market cap
- 222.34M
- Price
- $1.35+8.43% (1D)
- Market cap
- 351.40M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
72/100 ⭐⭐⭐⭐⭐
- Overall
- -0.1%
- NYSE
- -0.1%
- NASDAQ
- -0.1%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Consumer Defensive | +1.3% | +3.3% | +2.2% | 29.2 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.1% | +0.9% | +2.0% | 19.3 | 86/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.1% | +0.5% | +0.8% | 23.5 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | -0.7% | +0.1% | -1.3% | 24.9 | 60/100⭐⭐⭐⭐ |
| Energy | -0.4% | -2.0% | -2.4% | 19.4 | 51/100⭐⭐⭐ |
| Utilities | -1.5% | -0.5% | -4.9% | 25.4 | 40/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.1% | -3.5% | 29.4 | 36/100⭐⭐ |
| Industrials | -0.4% | -0.5% | -10.7% | 30.5 | 19/100⭐ |
| Consumer Cyclical | -0.3% | -2.3% | -6.5% | 43.1 | 17/100⭐ |
| Technology | -1.9% | -4.0% | -9.4% | 41.9 | 7/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.